SEC Form 4 · accession 0001209191-19-003728
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian B Hansen
Officer — EVP & CHIEF COMMERCIAL OFFICER
Period of report
Jan 15, 2019
Accepted (ET)
Jan 15, 2019 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 15, 2019 | M | 25,000 | $2.59 | A | 26,381 | D | |
| Common StockF3 | Jan 15, 2019 | S | 25,000 | $41.5411 | D | 1,381 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF4,F5 | $2.59 | Jan 15, 2019 | M | 25,000 | D | — | — | Common Stock | 25,000 | 50,000 | D |
Explanation of responses
- F1Represents shares of common stock received upon exercise of a stock option award.
- F2The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018.
- F3The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $41.25 and $41.93.
- F4The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.
- F5The expiration date for these options is 10 years from the date of grant.